DiaSorin Spa announced Wednesday that it has applied for 510 clearance from the U.S. Food and Drug Administration for the Liaison Plex Yeast Blood Culture Assay, the second multiplexing molecular.
The real-time RT-PCR Simplexa COVID-19 & Flu A/B Direct assay is designed for use on the company's Liaison MDX instrument, with results in about one hour.
DiaSorin S.p.A. (OTCPK:DSRLF) Q1 2022 Earnings Conference Call May 6, 2022 11:30 AM ET Company Participants Carlo Rosa – Chief Executive Officer Piergiorgio Pedron – Chief Financial Officer.